DNA Structure, Complementarity, and Replication
DNA Complementarity
- DNA complementarity refers to the base pairing rules.
- Base pair matching rules:
- Adenine (A) pairs with Thymine (T) via 2 hydrogen bonds.
- Guanine (G) pairs with Cytosine (C) via 3 hydrogen bonds.
- Example:
- If a DNA strand has the sequence 5'-ATGCTA-3', the complementary strand is:
- a) 5'-TACGAT-3'
- b) 3'-TACGAT-5' (correct answer)
- c) 5'-UACGAU-3' (not applicable as U is in RNA)
- d) 3'-ATGCTA-5' (not a valid complement)
DNA Structure
- Characteristics of DNA:
- The DNA double helix consists of two strands that are antiparallel.
- Answer: d) DNA strands are antiparallel (one 5'->3', one 3'->5').
- Sugar-phosphate backbone is on the outside, and nitrogenous bases are on the inside.
- Strands do not run parallel to each other.
DNA Replication
- Enzymes Involved:
- DNA polymerase is primarily responsible for synthesizing new DNA strands. (Answer: b)
- Other enzymes include:
- Helicase: unwinds the DNA helix.
- Ligase: joins Okazaki fragments.
- Central Dogma of Molecular Biology:
- Describes the flow of genetic information:
- b) DNA -> RNA -> Protein. (Correct)
Base Pairing Incorrectness
- Identify incorrect pairing:
- a) Adenine with Thymine (2 hydrogen bonds) (correct)
- b) Guanine with Cytosine (3 hydrogen bonds) (correct)
- c) Adenine with Uracil (in RNA) (correct)
- d) Guanine with Thymine (incorrect) (Correct answer)
Percentage of Bases
- If a double-stranded DNA molecule is 30% adenine:
- Cytosine would be 20% (20% due to complementary base pairing).
5' End Characteristics
- The 5' end of a DNA strand is characterized by:
- A free phosphate group on the 5' carbon of the sugar (Answer: a).
Semiconservative DNA Replication
- DNA replication is described as semiconservative because:
- Each new DNA molecule contains one original strand and one new strand (Answer: b).
Gene Expression, Transcription, Translation, and Alternative Splicing
Transcription
- Defined as:
- c) Making RNA from DNA (correct).
- Enzyme responsible for transcription:
- RNA polymerase (Answer: b).
- If the DNA template strand is 3'-TACGCA-5', the mRNA sequence will be:
- 5'-AUGCGU-3' (correct answer).
Alternative Splicing
- Definition:
- Producing different mRNA transcripts from the same gene by including/excluding different exons (Answer: b).
- Clinical significance:
- Alternative splicing can lead to multiple protein isoforms from one gene with different drug-metabolizing activities (Answer: b).
Translation
- The ribosome:
- c) Reads mRNA codons and assembles amino acids into protein (correct answer).
- Codon Definition:
- b) A three-nucleotide sequence in mRNA that codes for a specific amino acid (correct).
Introns, Exons, and Mutations
Introns and Exons
- True statement:
- b) Exons are expressed in the final protein; introns are removed during splicing (correct).
Nonsense Mutation
- Results in:
- b) A premature stop codon, leading to a truncated protein (correct).
CYP2D6 Alternative Splicing
- May create enzyme variants with altered substrate specificity (Answer: a).
Genetic Variation - Mutations, SNPs, Polymorphisms
- A single nucleotide polymorphism (SNP) is defined as:
- a) A DNA sequence variation occurring in >1% of the population at a single base pair position (correct).
- Difference between mutation and polymorphism:
- c) Polymorphisms typically occur in >1% of the population; mutations are rarer (correct).
Common Genetic Variants
- The MOST common genetic variant in the human genome is:
- b) Single nucleotide polymorphisms (SNPs) (correct).
Synonymous (Silent) Mutation
- Does not change the amino acid sequence due to codon degeneracy (Answer: c).
Missense Mutation
- Results in:
- b) A different amino acid being incorporated into the protein (correct).
Functional Consequences in Drug Metabolism
- c) Nonsynonymous SNP in the active site of a metabolizing enzyme (likely to have functional consequences) (correct).
Copy Number Variations (CNVs) and Pharmacogenetics
Copy Number Variations (CNVs)
- Defined as:
- b) Deletions or duplications of large DNA segments (1kb to several Mb) (correct).
CYP2D6 Gene Deletion & Phenotypes
- Results in:
- b) Poor metabolizer phenotype (correct).
Pharmacogenetics vs Pharmacogenomics
- Pharmacogenetics studies single genes/variants; pharmacogenomics studies genome-wide variation (Answer: b).
Pharmacodynamic Genes
- Primarily affect drug targets, receptors, and downstream signaling pathways (Answer: b).
Examples of Pharmacokinetic and Pharmacodynamic Genes
- Pharmacokinetic gene example: c) CYP2D6 (drug metabolizing enzyme).
- Pharmacodynamic gene example: d) VKORC1 (warfarin target enzyme).
Chromosomal Nomenclature and Genetic Markers
Chromosomal Nomenclature
- In chromosomal nomenclature:
- "p" refers to the short arm of the chromosome (Answer: b).
- "q" refers to the long arm of the chromosome (Answer: b).
- Example: The CYP2D6 gene location (22q13.2) means:
- b) Chromosome 22, long arm, region 1, band 3, sub-band 2 (correct).
Notation of Genetic Variants
- Correct description of a deletion on the short arm of chromosome 5:
- d) Both b and c (5p- and del(5p)).
- Notation "46,XY" indicates:
- a) A normal male karyotype with 46 chromosomes (correct).
- Centromere location affects chromosome arms:
- b) Metacentric chromosomes have the centromere in the middle; acrocentric have it near one end (correct).
Term "Locus"
- Refers to:
- a) A specific physical location of a gene on a chromosome (correct).
Haplotype and Linkage Disequilibrium
Haplotype
- Defined as:
- a) A set of alleles at multiple loci on the same chromosome inherited together (correct).
Diplotype
- Defined as:
- b) Two haplotypes (one from each parent) that make up an individual's genotype (correct).
- Haplotype phasing importance:
- b) Different haplotype combinations can result in different phenotypes even with the same genotype (correct).
CYP2C19 Heterozygosity
- In a patient heterozygous at two CYP2C19 SNP positions (681G>A and 636G>A), phasing is necessary to evaluate:
- b) Whether variants are on the same or different chromosomes (correct).
CYP2C19*2 Haplotype Definition
- Defined by:
- b) Multiple SNPs that travel together including 681G>A as the defining variant (correct).
Linkage Disequilibrium (LD)
- Linkage Disequilibrium (LD)
- Defined as:
- b) Non-random association of alleles at different loci (Answer: b).
- Tag SNPs:
- a) SNPs that mark a particular haplotype block and can represent multiple other SNPs in LD (correct).
- Complete Linkage Disequilibrium:
- b) Two alleles always occur together (perfect correlation) (correct).
- Reasons why a tag SNP may not be the causative variant:
- b) The tag SNP marks a haplotype block; the causative variant may be another SNP in LD (correct).
Mendelian Inheritance Patterns
Autosomal Recessive Inheritance
- An affected individual must have:
- b) Two copies of the variant allele (homozygous) (correct).
Autosomal Dominant Inheritance
- An individual with one copy of the variant allele:
- b) Will express the trait/disorder (correct).
Carrier Probability in Autosomal Recessive Inheritance
- If both parents are carriers, the probability their child will be affected:
- b) 25% (correct).
X-linked Recessive Traits
- Predominantly affect males; females are usually carriers (Answer: b).
CYP2D6 Inheritance
- Poor metabolizer phenotype follows:
- b) Autosomal recessive inheritance (need two non-functional alleles) (correct).
Genetic Concepts and Population Genetics
Codominance
- Means:
- b) Both alleles are expressed equally in the heterozygote (correct).
Incomplete Penetrance
- Means:
- a) Not all individuals with a disease genotype develop the disease phenotype (correct).
Hardy-Weinberg Equilibrium
- Equation:
- describes expected genotype frequencies in a population at equilibrium (correct).
- Assumptions of Hardy-Weinberg equilibrium include:
- a) Random mating, no migration, no mutation, no selection, large population (correct).
Expected Frequencies in Hardy-Weinberg Equilibrium
- If frequency of the CYP2C9*3 allele (q) is 0.1, the expected frequency of *3/*3 homozygotes is:
- a) 0.01 () (correct).
- If and , the expected frequency of 1/2 heterozygotes:
- b) 0.42 (2pq) (correct).
Violations of Hardy-Weinberg Equilibrium
- c) Natural selection favoring one allele (correct).
Differing Pharmacogene Allele Frequencies Between Populations
- Due to:
- b) Migration, genetic drift, founder effects, and possibly selection (correct).
Pharmacogenomics Applications
Investigating Functionally Significant SNPs
- To determine if a novel SNP in CYP2D6 is functionally significant, assess:
- b) If it changes amino acid sequence, is in a conserved region, and test enzyme activity (correct).
Assigning a Diplotype
- To assign a diplotype from SNP data, you need:
- b) Phasing information to determine variants on same chromosome (correct).
Importance of Tag SNPs in Pharmacogenomics
- Based on:
- b) Being in linkage disequilibrium with other SNPs in a haplotype block (correct).
Inferring Haplotype from Defining SNP
- From detecting the defining SNP (1846G>A) for CYP2D6*4 allele, one can infer:
- b) The entire *4 haplotype is likely present due to LD (correct).
Understanding Haplotype vs Genotype in Phenotypes
- Importance of understanding haplotypes:
- b) Heterozygous variants on same chromosome may retain functional copy; if on different chromosomes, may have no functional copies (correct).
Functional Relevance of Synonymous SNPs
- A synonymous SNP in an exon might still be functionally relevant because:
- b) It could affect mRNA splicing, mRNA stability, or translation efficiency (correct).
Designing Pharmacogenomic Panels
- To minimize cost while maximizing information, use:
- b) Tag SNPs to capture haplotype variation (correct).
Variability in Drug Clearance
- A drug metabolized by CYP2D6 shows variability in clearance likely due to:
- b) Genetic polymorphisms in CYP2D6 (poor to ultrarapid metabolizers) (correct).
Alternative Splicing Outcomes
- Could produce:
- b) Multiple protein isoforms with different catalytic activities (correct).